Add BrightSurf on Google Email

Rockefeller University Press


(Antibody) orientation matters

A study found that antibodies attached to bacteria via their Fc regions in saliva, while in blood they bound primarily via their Fab regions. This difference in orientation was linked to the local antibody concentration, with low levels favoring Fc-mediated binding and high levels favoring Fab-mediated binding.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateDec 10, 2012

Helping ex-smokers resist the urge

A new inhibitor has been shown to decrease relapses in ex-smoker rats by preventing the interaction of two neurotransmitter receptors in the brain. The study found that long-term nicotine exposure causes these receptors to interact, leading to increased cravings.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateOct 22, 2012

Sugar-free approach to treating Kaposi sarcoma

Researchers found that blocking galectin-1 in mice with established Kaposi sarcomas slowed tumor growth by suppressing blood vessel formation. This breakthrough holds promise for new treatment options for patients with KS and may also be effective for other diseases characterized by aberrant blood vessel growth.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateOct 1, 2012

Fitting Kv potassium channels in the PIP2 puzzle

A recent study in the Journal of General Physiology reveals that Kv potassium channels are not regulated by physiological changes to PIP2. In contrast to inward rectifier channels, various members of the Kv channel family were unaffected by PIP2 depletion, suggesting a previously unknown mechanism for their regulation.

SourceRockefeller University Press·JournalJournal of General Physiology·DateAug 27, 2012

Ovastacin cuts off sperm binding

Researchers discovered that ovastacin, an astacin family member, cleaves the ZP2 protein in the zona pellucida matrix surrounding eggs. This proteolysis blocks additional sperm binding, preventing polyspermy and ensuring embryonic development. Ovastacin's function is crucial for single fertilization.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateApr 2, 2012

New memory for HIV patients

A study published in the Journal of Experimental Medicine suggests that replacing naive CD4+ T cells with memory CD4+ T cells may be a more effective approach to combating HIV. The loss of naive T cells had no effect on the maintenance of memory CD4+ T cells, whose loss proceeded similarly with or without naive cell replacements.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateMar 26, 2012

Lasting T cell memories

A recent study published in the Journal of Experimental Medicine found that humans can build up memory T cell numbers over time without sacrificing old ones, unlike previous studies on mice that suggested space limitations. The discovery has significant implications for understanding human immune responses and potential treatments.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateMar 5, 2012

How autoreactive T cells slip through the cracks

Researchers found that autoreactive T cells from patients with multiple sclerosis and type 1 diabetes bound their targets more weakly than helpful T cells. These autoaggressive T cells may slip through safety screens by failing to notice their targets, suggesting a new mechanism for autoimmune disease progression.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateFeb 6, 2012

A firmer understanding of muscle fibrosis

Researchers discovered that increased production of microRNA miR-21 stimulates progressive muscle deterioration in a mouse model of Duchenne muscular dystrophy. Inhibiting miR-21 reduced collagen levels and prevented fibrogenesis in diseased animals, suggesting it as a potential therapeutic target.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateJan 2, 2012

2-faced leukemia?

A study found that half of tumors from T-cell acute lymphoblastic leukemia (T-ALL) patients expressed genes normally found in stem cells and acute myeloid leukemia (AML) tumors. Additionally, many of these AML-like T-ALL tumors contained specific mutations associated with cancer progression.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateDec 12, 2011

How brain tumors invade

Researchers identified a key protein mutation that enables brain tumors to invade healthy brain tissue. Excessive epidermal growth factor receptor (EGFR) signals trigger the production of GBP1, rendering tumors more invasive and allowing them to spread into surrounding tissue.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateDec 12, 2011

What wakes dormant tumor cells

A study published in the Journal of Experimental Medicine reveals that protein BMP7 signals prostate tumor cells to enter a state of dormancy. Withdrawal of this protein restarts tumor growth, offering potential new therapies to prevent recurrence.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateNov 28, 2011

New perspectives on sensory mechanisms

The Perspectives in General Physiology series provides an in-depth look at the mechanisms of sensory information processing, including visual, auditory, olfactory, and tactile processes. The series reveals key strategies used by researchers to quantify and characterize sensory information across multiple systems.

SourceRockefeller University Press·JournalJournal of General Physiology·DateAug 29, 2011

Aurora A may contribute to kidney disease

Researchers found that Aurora A was up-regulated and activated in epithelial cells lining PKD patient kidneys, binding to and phosphorylating polycystin-2. Inhibition of Aurora A boosted intracellular calcium levels, suggesting it may be a viable therapeutic target for boosting polycystin-2 activity in certain patients.

SourceRockefeller University Press·JournalJournal of Cell Biology·DateJun 13, 2011